In lung cancer, CLDN1 expression was reported to promote the chemotherapeutic resistance of NSCLC through ULK1 phosphorylation, but methylation of the CLDN1 gene can enhance the efficacy of chemotherapy to inhibit the progress of LUAD [53]. This evidence concerns the gene CLDN1 and lung carcinoma.